(Total Views: 381)
Posted On: 01/06/2018 7:29:11 PM
Post# of 30034
Re: jamiejaytrader #25926
We know what you meant.
Elto is worthless.
jk
The irony is dyskinesia is the side effect from the rare disease Parkinsons, not the rare disease itself.
All what you said is true. I will add unfortunately there are new patients all the time and if they have more than one choice, that is a good thing.
The second thing I assumed, but did want to look up first before I spoke is there is no perfect drug. Not all drugs will work for all people. I wanted to see what the side effects of GOCOVRI are.
Table 1 starting on page 6 is the list Hallucinations was number 1 at 21% compared to placebo at 3%. The other troubling number a few pages earlier is suicidal thoughts or suicide attempts were in 2% of the patients. Hopefully that was only in the trial and doesn't happen with new patients.
Maybe Tanis can weigh in on the suicide thing as I remember hearing commercials on TV mention that in the disclaimer they say real fast. Maybe many drugs have that risk and it's par for the course.
Elto is worthless.
jk
The irony is dyskinesia is the side effect from the rare disease Parkinsons, not the rare disease itself.
All what you said is true. I will add unfortunately there are new patients all the time and if they have more than one choice, that is a good thing.
The second thing I assumed, but did want to look up first before I spoke is there is no perfect drug. Not all drugs will work for all people. I wanted to see what the side effects of GOCOVRI are.
Table 1 starting on page 6 is the list Hallucinations was number 1 at 21% compared to placebo at 3%. The other troubling number a few pages earlier is suicidal thoughts or suicide attempts were in 2% of the patients. Hopefully that was only in the trial and doesn't happen with new patients.
Maybe Tanis can weigh in on the suicide thing as I remember hearing commercials on TV mention that in the disclaimer they say real fast. Maybe many drugs have that risk and it's par for the course.
(3)
(0)Scroll down for more posts ▼
